and use of the index drug for 90 days (with 60-day gaps)
Co-treatment with QT and LC, either niosomal or conventional, significantly improved oxidant-antioxidant markers
The FDA approved Foundayo on April 1, 2026, for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who have at least one weight-related health condition, addressing a population where 40.3% of US adults have obesity
A new generation of breakthrough weight loss drugs, like Ozempic/Wegovy and Mounjaro/Zepbound, is ushering in the biggest pharmaceutical market on the planet potentially worth $500bn by 2030
The animals food consumption and weight gain were monitored constantly for 16 weeks
The Importance of Glutathione Levels As we age, our natural levels of glutathione tend to decline